---
title: "Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions"
date: "2024-09-24T09:41:55.000Z"
publishedDate: "24 septembre 2024"
summary: "A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024 (30 August–2 September, London, UK). Muthiah Vaduganathan [&#8230;] The post Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pooled-analysis-of-over-18000-participants-supports-benefits-of-finerenone-across-cardio-kidney-metabolic-conditions/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-09-24-pooled-analysis-of-over-18000-participants-supports-benefits-of-finerenone-across-cardio-kidney-metabolic-conditions"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/09/ESC-logo-feature-image.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pooled-analysis-of-over-18000-participants-supports-benefits-of-finerenone-across-cardio-kidney-metabolic-conditions/"
---

![Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/09/ESC-logo-feature-image.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pooled-analysis-of-over-18000-participants-supports-benefits-of-finerenone-across-cardio-kidney-metabolic-conditions/*

## L’essentiel

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024 (30 August–2 September, London, UK). Muthiah Vaduganathan [&#8230;] The post Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/pooled-analysis-of-over-18000-participants-supports-benefits-of-finerenone-across-cardio-kidney-metabolic-conditions/
